Global Pneumococcal Vaccine Market 2016-2020
About Pneumococcus
Pneumococcus (Streptococcus pneumoniae), a pathogenic bacterium, is the leading cause of serious illness
worldwide. It is the major cause of pneumonia, blood infections, meningitis, sinusitis, and middle ear infections
(otitis media). Pneumococcal infections affect children younger than five years and older people (65 years and
older), and it is among the leading infectious disease. It kills almost 1.6 million people (including over 800,000
children under five years) every year. It can be prevented by vaccination and involves the introduction of a dead or
weakened antigen into the human body. This produces lymphocytes to counter the infection and any future
invasions by that antigen.
Publisher's analysts forecast the global pneumococcal vaccine market to grow at a CAGR of 13.69% during the
period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global pneumococcal vaccine market for
2016-2020. To calculate the market size, the report considers revenue generated from the sales of vaccines used to
prevent pneumococcal infections.
The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA
View Complete Report @ http://www.reportsweb.com/global-pneumococcal-vaccine-market-2016-
2020
Contact Us : +91-20-67278686 | E-Mail : [email protected]